Pacific Biosciences of California, Inc. (PACB)
USD 1.33
(-3.99%)
USD 1.33
(-3.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 753.71 Million USD | 19.21% |
| 2022 | 632.27 Million USD | 28.25% |
| 2021 | 493.02 Million USD | 278.11% |
| 2020 | -276.81 Million USD | -2301.66% |
| 2019 | 12.57 Million USD | 400.43% |
| 2018 | -4.18 Million USD | 91.5% |
| 2017 | -49.23 Million USD | -7371.47% |
| 2016 | -659 Thousand USD | 99.02% |
| 2015 | -67.32 Million USD | -201.55% |
| 2014 | -22.32 Million USD | -114.62% |
| 2013 | -10.4 Million USD | 76.23% |
| 2012 | -43.75 Million USD | 21.78% |
| 2011 | -55.93 Million USD | 61.32% |
| 2010 | -144.61 Million USD | -62.06% |
| 2009 | -89.23 Million USD | -15.64% |
| 2008 | -77.16 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 854.42 Million USD | 13.36% |
| 2024 Q2 | 825.08 Million USD | -3.39% |
| 2023 FY | 753.71 Million USD | 19.21% |
| 2023 Q2 | 728.35 Million USD | 23.24% |
| 2023 Q3 | 979.11 Million USD | 34.43% |
| 2023 Q4 | 753.71 Million USD | -23.02% |
| 2023 Q1 | 590.99 Million USD | -6.53% |
| 2022 Q3 | 643.87 Million USD | 0.64% |
| 2022 Q4 | 632.27 Million USD | -1.8% |
| 2022 FY | 632.27 Million USD | 28.25% |
| 2022 Q1 | 523.44 Million USD | 6.17% |
| 2022 Q2 | 639.77 Million USD | 22.22% |
| 2021 Q2 | 476.04 Million USD | 11210.12% |
| 2021 Q3 | 527.6 Million USD | 10.83% |
| 2021 Q4 | 493.02 Million USD | -6.56% |
| 2021 FY | 493.02 Million USD | 278.11% |
| 2021 Q1 | 4.2 Million USD | 101.52% |
| 2020 Q3 | -165.54 Million USD | -117.82% |
| 2020 Q2 | -75.99 Million USD | 22.23% |
| 2020 Q1 | -97.72 Million USD | -877.23% |
| 2020 Q4 | -276.81 Million USD | -67.22% |
| 2020 FY | -276.81 Million USD | -2301.66% |
| 2019 Q1 | 25.11 Million USD | 700.12% |
| 2019 Q3 | 29.15 Million USD | -10.09% |
| 2019 FY | 12.57 Million USD | 400.43% |
| 2019 Q4 | 12.57 Million USD | -56.87% |
| 2019 Q2 | 32.42 Million USD | 29.11% |
| 2018 Q4 | -4.18 Million USD | 95.87% |
| 2018 FY | -4.18 Million USD | 91.5% |
| 2018 Q3 | -101.36 Million USD | -1034.19% |
| 2018 Q1 | -11.58 Million USD | 76.47% |
| 2018 Q2 | -8.93 Million USD | 22.86% |
| 2017 Q3 | -12.56 Million USD | 46.28% |
| 2017 FY | -49.23 Million USD | -7371.47% |
| 2017 Q4 | -49.23 Million USD | -291.76% |
| 2017 Q1 | -12.55 Million USD | -1805.46% |
| 2017 Q2 | -23.39 Million USD | -86.3% |
| 2016 Q3 | -7 Million USD | 24.59% |
| 2016 FY | -659 Thousand USD | 99.02% |
| 2016 Q1 | -76.31 Million USD | -13.36% |
| 2016 Q2 | -9.28 Million USD | 87.84% |
| 2016 Q4 | -659 Thousand USD | 90.59% |
| 2015 Q4 | -67.32 Million USD | -52.65% |
| 2015 Q2 | -11.36 Million USD | 28.68% |
| 2015 Q1 | -15.93 Million USD | 28.64% |
| 2015 FY | -67.32 Million USD | -201.55% |
| 2015 Q3 | -44.1 Million USD | -288.11% |
| 2014 Q4 | -22.32 Million USD | -3.85% |
| 2014 Q3 | -21.49 Million USD | -48.4% |
| 2014 Q2 | -14.48 Million USD | 85.77% |
| 2014 FY | -22.32 Million USD | -114.62% |
| 2014 Q1 | -101.8 Million USD | -878.7% |
| 2013 Q2 | -89.07 Million USD | -137.92% |
| 2013 Q4 | -10.4 Million USD | 90.54% |
| 2013 Q3 | -109.92 Million USD | -23.41% |
| 2013 Q1 | -37.44 Million USD | 14.43% |
| 2013 FY | -10.4 Million USD | 76.23% |
| 2012 FY | -43.75 Million USD | 21.78% |
| 2012 Q4 | -43.75 Million USD | -47.15% |
| 2012 Q3 | -29.73 Million USD | 3.34% |
| 2012 Q2 | -30.76 Million USD | 42.36% |
| 2012 Q1 | -53.36 Million USD | 4.6% |
| 2011 Q2 | -51.52 Million USD | 36.85% |
| 2011 Q1 | -81.6 Million USD | 43.57% |
| 2011 Q4 | -55.93 Million USD | -2.41% |
| 2011 Q3 | -54.62 Million USD | -6.01% |
| 2011 FY | -55.93 Million USD | 61.32% |
| 2010 FY | -144.61 Million USD | -62.06% |
| 2010 Q3 | -59.66 Million USD | 33.77% |
| 2010 Q2 | -90.08 Million USD | 0.0% |
| 2010 Q4 | -144.61 Million USD | -142.37% |
| 2009 FY | -89.23 Million USD | -15.64% |
| 2009 Q4 | -89.23 Million USD | 0.0% |
| 2008 FY | -77.16 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 1.27 Million USD | -58893.204% |
| Talis Biomedical Corporation | -57.06 Million USD | 1420.831% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 14806.712% |
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -2683.099% |
| Bioventus Inc. | 372.51 Million USD | -102.334% |
| Cerus Corporation | 84.35 Million USD | -793.54% |
| CVRx, Inc. | -59.95 Million USD | 1357.12% |
| electroCore, Inc. | -9.95 Million USD | 7671.261% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -37887.093% |
| OrthoPediatrics Corp. | -9.26 Million USD | 8233.366% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 20800.879% |
| Spectral AI, Inc. | -3.5 Million USD | 21628.678% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 5854.881% |
| BrainsWay Ltd. | -10.32 Million USD | 7403.479% |
| Envoy Medical, Inc. | -3.81 Million USD | 19861.904% |
| MaxCyte, Inc. | -27.76 Million USD | 2814.833% |
| NanoVibronix, Inc. | -3.27 Million USD | 23093.258% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 1669.365% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 131006.947% |
| Orthofix Medical Inc. | 96.44 Million USD | -681.526% |
| Inogen, Inc. | -103.56 Million USD | 827.746% |
| IceCure Medical Ltd | -9.93 Million USD | 7687.266% |
| PAVmed Inc | 29.08 Million USD | -2491.346% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -24462.116% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 4549.607% |
| RxSight, Inc. | -6.68 Million USD | 11383.219% |
| Sight Sciences, Inc. | -102.71 Million USD | 833.796% |
| SI-BONE, Inc. | 5.72 Million USD | -13074.602% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 14769.236% |
| TELA Bio, Inc. | -3.94 Million USD | 19186.326% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 7502.465% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -1214.909% |
| Venus Concept Inc. | 74.3 Million USD | -914.413% |
| Acutus Medical, Inc. | 12.27 Million USD | -6038.277% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -214024.716% |
| LivaNova PLC | 62.53 Million USD | -1105.333% |
| 908 Devices Inc. | -115.09 Million USD | 754.861% |
| Alphatec Holdings, Inc. | 320.7 Million USD | -135.016% |
| Nemaura Medical Inc. | 9.92 Million USD | -7494.134% |
| NeuroPace, Inc. | 54.33 Million USD | -1287.119% |
| LENSAR, Inc. | -18.31 Million USD | 4215.984% |
| Apyx Medical Corporation | -5.15 Million USD | 14732.479% |
| Cutera, Inc. | 288.3 Million USD | -161.436% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -9929.528% |
| BioSig Technologies, Inc. | 262 Thousand USD | -287579.008% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 1819.642% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 8293.488% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 46.365% |
| Axonics, Inc. | -77.19 Million USD | 1076.396% |
| Outset Medical, Inc. | 67.67 Million USD | -1013.667% |
| IRIDEX Corporation | -4.28 Million USD | 17677.402% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 523.395% |
| IRadimed Corporation | -47.71 Million USD | 1679.489% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 25008.096% |
| INVO Bioscience, Inc. | 8.45 Million USD | -8818.551% |
| Telesis Bio, Inc. | 32.63 Million USD | -2209.542% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 30223.071% |
| Varex Imaging Corporation | 316.9 Million USD | -137.841% |
| Quipt Home Medical Corp. | 81.73 Million USD | -822.155% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 27192.703% |
| Pulmonx Corporation | -42.36 Million USD | 1879.318% |
| Dynatronics Corporation | 6.2 Million USD | -12048.855% |
| Modular Medical, Inc. | -8.04 Million USD | 9472.283% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 17640.586% |
| Semler Scientific, Inc. | -57.13 Million USD | 1419.305% |
| InMode Ltd. | -135.39 Million USD | 656.686% |
| Bruker Corporation | 891.3 Million USD | 15.436% |
| Cytosorbents Corporation | 4.18 Million USD | -17922.867% |
| DexCom, Inc. | 2.02 Billion USD | 62.829% |
| Align Technology, Inc. | -840.47 Million USD | 189.678% |
| Viveve Medical, Inc. | -13.81 Million USD | 5556.592% |
| ZimVie Inc. | 450.41 Million USD | -67.337% |
| Movano Inc. | -5.86 Million USD | 12948.943% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 660.569% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 131006.947% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -37887.093% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | -111.245% |
| Profound Medical Corp. | -18.17 Million USD | 4246.208% |
| Insulet Corporation | 798.1 Million USD | 5.561% |
| enVVeno Medical Corporation | -2.21 Million USD | 34081.921% |
| Surmodics, Inc. | -12.01 Million USD | 6373.672% |
| iCAD, Inc. | -21.2 Million USD | 3653.77% |
| Nuwellis, Inc. | -2.81 Million USD | 26837.105% |
| Biotricity, Inc. | 23.09 Million USD | -3163.88% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -704.817% |
| Aethlon Medical, Inc. | -4.5 Million USD | 16843.127% |
| InspireMD, Inc. | -8.04 Million USD | 9468.788% |
| PAVmed Inc. | 29.08 Million USD | -2491.346% |
| BIOLASE, Inc. | 11.34 Million USD | -6544.208% |
| Beyond Air, Inc. | 6.22 Million USD | -12000.161% |
| FONAR Corporation | -14.66 Million USD | 5239.464% |
| AxoGen, Inc. | 32.26 Million USD | -2235.954% |
| Vivani Medical, Inc. | 42 Thousand USD | -1794469.048% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 7171.862% |
| Inari Medical, Inc. | -7.16 Million USD | 10625.33% |
| UFP Technologies, Inc. | 40.77 Million USD | -1748.528% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 15896.899% |
| Tenon Medical, Inc. | -1.25 Million USD | 60157.291% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 10009.532% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 6419.8% |
| AdaptHealth Corp. | 2.21 Billion USD | 66.011% |
| Sintx Technologies, Inc. | 905 Thousand USD | -83183.867% |
| Quanterix Corporation | -132.95 Million USD | 666.885% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 27192.703% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 3470.083% |
| TransMedics Group, Inc. | 121.13 Million USD | -522.219% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 2978.988% |
| NeuroMetrix, Inc. | -1.49 Million USD | 50648.868% |
| Hyperfine, Inc. | -75.61 Million USD | 1096.732% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -395.252% |
| Biomerica, Inc. | -3.38 Million USD | 22366.44% |
| Bone Biologics Corporation | -3.02 Million USD | 25003.414% |
| AVITA Medical, Inc. | -26.23 Million USD | 2973.323% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 41098.395% |
| Silk Road Medical, Inc | 64.42 Million USD | -1069.953% |